Biocon Ltd. — Capital/Financing Update 2025

Jan 27, 2025

==> picture [132 x 52] intentionally omitted <==

Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T: 91 80 2808 2808 F: 91 80 2852 3423 CIN : L24234KA1978PLC003417 www.biocon.com

BIO/SECL/SP/2024-25/160

January 27, 2025

To, The Secretary BSE Limited Department of Corporate Services Phiroze Jeejeebhoy Towers, Dalal Street,Mumbai – 400 001	To, The Secretary National Stock Exchange of India Limited Corporate Communication Department Exchange Plaza, Bandra Kurla Complex Mumbai – 400 050
Scrip Code – 532523	Scrip Symbol - Biocon

Dear Sir/Madam,

Subject: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors at its meeting held today, i.e. on Monday, January 27, 2025, has approved issuance of Commercial Papers of Rs. 570 Crores on private placement basis.

The above-mentioned information will also be available on website of the Company at www.biocon.com.

Further, the Board Meeting commenced at 9:00 AM and concluded at 9:20 A.M.

Kindly take the above information on record and acknowledge.

Thanking You,

==> picture [73 x 76] intentionally omitted <==

==> picture [89 x 67] intentionally omitted <==

----- Start of picture text -----

For Biocon Limited
Digitally signed
MAYANK by MAYANK
VERMA
VERMA Date: 2025.01.27
09:29:58 +05'30'
___
----- End of picture text -----

Mayank Verma Company Secretary and Compliance Officer Membership No.: ACS 18776